Oral PRI-002 Trial Shows Promise for Early Alzheimer’s
In a landmark advancement in neurodegenerative disease therapeutics, researchers have unveiled promising results from a randomized, double-blind phase 1b clinical...
Diana Fleming is a Scienmag editorial specialist profile for Neurodegenerative Diseases coverage.
In a landmark advancement in neurodegenerative disease therapeutics, researchers have unveiled promising results from a randomized, double-blind phase 1b clinical...
Could a simple retinal examination revolutionize the early diagnosis of Parkinson’s disease? This provocative possibility has gained substantial traction following...
In a groundbreaking development in neurodegenerative disease research, advances in positron emission tomography (PET) tracer technology are revolutionizing the diagnosis...
Parkinson’s disease, a relentless neurodegenerative disorder, has long challenged scientists and clinicians due to its complex pathology and elusive early...
In a groundbreaking advancement for Parkinson’s disease therapy, researchers have reported the results of a first-in-human Phase I/II clinical trial...
A groundbreaking advancement in the early detection of Alzheimer’s disease has emerged from an international collaboration of researchers affiliated with...
A groundbreaking advancement in artificial intelligence (AI) has emerged, providing a pivotal insight into the perplexing mechanisms of neurodegenerative disorders...
Vibrotactile perception has emerged as a focal point in the realm of sensory input for individuals afflicted with Parkinson's Disease...
In recent years, wearables have increasingly become a prominent tool in the field of health research, particularly for chronic conditions...
Researchers at the Hebrew University of Jerusalem have pioneered a groundbreaking blood test that could fundamentally change the landscape of...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine